Pyc Therapeutics Stock Fundamentals
| PYC Stock | 1.40 0.05 3.45% |
PYC Therapeutics fundamentals help investors to digest information that contributes to PYC Therapeutics' financial success or failures. It also enables traders to predict the movement of PYC Stock. The fundamental analysis module provides a way to measure PYC Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PYC Therapeutics stock.
At this time, PYC Therapeutics' Interest Income is comparatively stable compared to the past year. Net Interest Income is likely to gain to about 784.1 K in 2024, despite the fact that EBIT is likely to grow to (37.2 M). PYC | Select Account or Indicator |
PYC Therapeutics Company Return On Equity Analysis
PYC Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current PYC Therapeutics Return On Equity | -0.7 |
Most of PYC Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PYC Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
PYC Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, PYC Therapeutics has a Return On Equity of -0.6961. This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The return on equity for all Australia stocks is notably higher than that of the company.
PYC Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PYC Therapeutics's current stock value. Our valuation model uses many indicators to compare PYC Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PYC Therapeutics competition to find correlations between indicators driving PYC Therapeutics's intrinsic value. More Info.PYC Therapeutics is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PYC Therapeutics' earnings, one of the primary drivers of an investment's value.PYC Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PYC Therapeutics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PYC Therapeutics could also be used in its relative valuation, which is a method of valuing PYC Therapeutics by comparing valuation metrics of similar companies.PYC Therapeutics is currently under evaluation in return on equity category among its peers.
PYC Fundamentals
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.38 | ||||
| Profit Margin | (1.71) % | ||||
| Operating Margin | (1.78) % | ||||
| Current Valuation | 587.49 M | ||||
| Shares Outstanding | 466.61 M | ||||
| Shares Owned By Insiders | 59.23 % | ||||
| Shares Owned By Institutions | 0.57 % | ||||
| Price To Book | 8.12 X | ||||
| Price To Sales | 29.61 X | ||||
| Revenue | 22.06 M | ||||
| Gross Profit | 15.81 M | ||||
| EBITDA | (38.12 M) | ||||
| Net Income | (37.73 M) | ||||
| Cash And Equivalents | 15.57 M | ||||
| Total Debt | 1.11 M | ||||
| Book Value Per Share | 0.02 X | ||||
| Cash Flow From Operations | (38.59 M) | ||||
| Earnings Per Share | (0.10) X | ||||
| Target Price | 8.75 | ||||
| Beta | 0.6 | ||||
| Market Capitalization | 653.25 M | ||||
| Total Asset | 91.24 M | ||||
| Retained Earnings | (155.89 M) | ||||
| Working Capital | 76.51 M | ||||
| Net Asset | 91.24 M |
About PYC Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PYC Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PYC Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PYC Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.3 M | 1.3 M | |
| Cost Of Revenue | 1.1 M | 1.5 M | |
| Total Revenue | 22.1 M | 23.2 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PYC Stock Analysis
When running PYC Therapeutics' price analysis, check to measure PYC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PYC Therapeutics is operating at the current time. Most of PYC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PYC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PYC Therapeutics' price. Additionally, you may evaluate how the addition of PYC Therapeutics to your portfolios can decrease your overall portfolio volatility.